The global market for blood-brain barrier (BBB) technology for therapeutics amounted to $12.3 million in 2010 and will reach $387 million by 2015, a compound annual growth rate (CAGR) of 99.3%.
Learn about the current status of the global therapeutic market for blood-brain barrier (BBB) technologies, including its growth potential over a 5-year period from 2010 to 2015. BCC analyzes each technology, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next 5 years. Technological issues, including the latest trends, are discussed…
Use this report to:
- Understand the latest research and trends in blood-brain barrier (BBB) technology, drug development, and drug delivery methods
- Identify opportunities for investment, alliances, and research collaborations to use technology to cross the BBB, as well as which technologies show the most promise in the growing central nervous system therapeutic market
- Evaluate potential opportunities arising from the increasing commercialization of biologics-based drugs that require some sort of BBB technology adaptation
- Develop strategies to address the challenges involved in BBB technologies and in developing CNS therapeutics.
To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.
GLOBAL MARKET FOR BBB TECHNOLOGY FOR THERAPEUTICS, THROUGH 2015 ($ MILLIONS)